DSIP in the sleep recordings
The name began with a recognizable electrical pattern. The later experiments complicate the picture before the morning even arrives.
Delta and spindle activity in rabbits
The original characterization of DSIP described a peptide that enhanced delta and spindle EEG activity when infused into rabbits' brain ventricles. EEG is a recording of the brain's electrical activity. Here the evidence was a particular pattern in that recording, under those experimental conditions.
I can appreciate why such a finding would invite a memorable name. A concrete signal offers something to pursue. An infusion into a rabbit's brain ventricle also leaves a long way to travel before an account of ordinary human sleep. For me, the experiment's interest survives with the animal and the route still in the frame.
The human sleep experiment
The study in six middle-aged people with chronic insomnia used intravenous synthetic DSIP. It reported longer sleep duration, fewer interruptions, slightly more REM sleep and no daytime sedation. The sleep-promoting effect appeared in the second hour, following slight arousal in the first.
That sequence surprised me. Even the encouraging human result took a less tidy course than an immediate drift into sleep. It makes the recording period matter: an account ending too early could miss the part that interested the investigators.
This is the human observation that drew me toward the morning question. Its small chronic-insomnia group gives it a defined place in the story. I hesitate over that extension to every tired person who recognizes the wish for better sleep.

Native DSIP and altered peptides
A later study in rabbits with implanted electrodes found no statistically significant sleep effect for native DSIP compared with saline. Most of the altered peptides tested also lacked a significant effect, while some increased slow-wave sleep and another suppressed it. The molecules did not all pull in the same direction.
The disagreement occupies my thoughts longer than the impressive name. Collecting every favorable finding under the single word DSIP would conceal exactly the distinction the experiment exposed. I want the ordinary molecule to answer for its own performance.
The review published in 2006 similarly described clearer sleep effects for artificial analogs than for native DSIP and characterized the overall sleep evidence as weak. That is a sobering place for the original claim to have arrived. The human measurements around sleep onset bring a different complication, this time in circulating DSIP-like material.